Research and Development

Four industry trade associations including pharma body the ABPI have banded together to form a new lobbying group representing life …

Novartis’ generics unit Sandoz has begun mid-stage trials of a biosimilar version of Roche’s blockbuster drug MabThera. The phase II …

The FDA has launched a new online resource to increase the transparency of its processes and help save companies time …

Sanofi-Aventis and Genzyme have come back to the negotiation table to discuss the potential of Genzyme’s multiple sclerosis drug Campath. …

GlaxoSmithKline has signed a worldwide licence agreement for a novel antibody designed to treat autoimmune diseases.The company will pay up …

Sanofi-Aventis workers have gone on strike in France as the company looks to cut jobs. Nine unions representing workers at …

A new study confirms that Roche’s Avastin is linked to a small but significant increased risk of heart failure in …

Biogen Idec has a new head of research and development, appointing Douglas Williams to oversee its global operations. The position …

Merck KGaA has opened a new technology centre near Mumbai in India that will offer a range of research services …

Private equity firm Warburg Pincus buys RPS for $227 million, plus updates from BASi, Almac, Caliper, and Critical Path Services/Accel …

 

Clinical research is rapidly moving toward the electronic environment as more  han half of all studies are conducted utilizing EDC, …

Novo Nordisk has appointed Dr Anne Phillips as vice president for clinical, medical and regulatory affairs for North America. She …

Some individuals believe not much has changed in Phase 1 dose escalation studies. A recent review1 that looked at 105 …

Swiss drugmaker Novartis is planning to spend $36 million to set up an R&D laboratory on the site of its …